Behnam Badie, MD, Neurosurgery, Arcadia, CA, City of Hope's Helford Clinical Research Hospital


NeurosurgeryArcadia, CA

Brain & Spinal Tumor, Pituitary Surgery, Skull Base

Chief, Division of Neurosurgery | Director, Brain Tumor Program | Vice Chair & Professor, Department of Surgery at City of Hope

Overview of Dr. Badie

I am a board certified neurosurgeon and current vice chair & professor, Department of Surgery and chief, Division of Neurosurgery at City of Hope in Duarte, California. I am also the director of the Brain Tumor Program at City of Hope.

I am an expert in the field of surgical neuro-oncology, and our Brain Tumor Program and Division of Neurosurgery is leading groundbreaking research into nanotechnology as a tool for delivering cancer-fighting drugs directly into tumors, in a minimally invasive manner.

Education & Training

  • UCLA Medical Center
    UCLA Medical CenterResidency
  • UCLA Medical Center
    UCLA Medical CenterInternship
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAMedicalSchool

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 1996 - Present
  • CA State Medical License
    CA State Medical License 1991 - 2020
  • American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014
  • Top Doctors:LA Area Castle Connolly, 2013
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Join now to see all

Clinical Trials

Publications & Presentations


Press Mentions

  • City of Hope Investigators Receive $4.1M for Clinical Trial Applying CAR T Cells Targeting Dangerous Brain CancerOctober 21, 2019
  • City of Hope Scientist Receives $9.28 Million for CAR T Cell Immunotherapy Clinical Trial for Patients with HER2-Positive Breast Cancer That Has Spread to the BrainAugust 13, 2019
  • Mustang Bio Announces Presentations on CAR T Therapies at 4th Annual CAR-TCR Summit 2018September 04, 2018
  • Join now to see all

Grant Support

  • Novel Cell Delivery Method for Brain Tumor TherapyNational Cancer Institute (NCI)2014–Present
  • Dynamic Magnetic Targeting of Activated Brain Macrophages for Glioma TherapyNINDS2013–Present
  • Role Of Receptor For Advanced Glycation END Product (RAGE) Pathway In Brain TumorNational Cancer Institute2011
  • Application Of Carbon Nanotubes For Macrophage Activation In Brain Tumor ModelsNational Cancer Institute2009–2010

Professional Memberships

Other Languages

  • Farsi

Hospital Affiliations